 |
|
Heparin in Acute Stroke With Atrial Fibrillation
Clinical Relevance of Very Early Treatment
Angel Chamorro, MD;
Nicolas Vila, MD;
Carlos Ascaso, PhD;
Rosa Blanc, MD
Arch Neurol. 1999;56:1098-1102.
Background The risk-benefit ratio of early vs late heparinization for acute stroke with nonvalvular atrial fibrillation remains unsettled.
Objective To clarify the relationship between timing to heparinization and functional outcome in acute cardioembolic stroke.
Design Consecutive case series.
Setting Referral center.
Patients In 231 patients with stroke and nonvalvular atrial fibrillation, intravenous or subcutaneous heparin administered with the goal of achieving an activated partial thromboplastin time (APTT) 1.5 to 2.0 times control values. Delay to the initiation of heparin therapy was less than 6 hours from the onset of symptoms in 74 patients and between 6 and 48 hours in 157 patients. Functional outcome (Rankin scale) was assessed 9±3 (mean±SD) days from stroke onset using multivariate analysis and including in the model treatment delay, risk factors (eg, age, hypertension, diabetes, hypercholesterolemia, previous stroke, and heart disease), initial neurological severity, and baseline computed tomographic findings (eg, early signs of infarction and white matter abnormalities). Clinical symptoms on admission (Mathew score) and baseline radiological findings were evaluated in all subjects. The bleeding rate was assessed on subsequent computed tomographic (CT) scans (obtained 7±2 days after stroke). The relationship between APTT ratios and stroke recurrence or hemorrhagic worsening was also tested.
Main Outcome Measures Functional outcome at hospital discharge and incidence of early recurrent strokes and bleeding complications.
Results Mortality (9%), hemorrhagic worsening (3.4%), and early stroke recurrence (2.1%) occurred in the hospital. Complete recovery was associated with age younger than 70 years (odds ratio [OR], 0.21; 95% confidence interval [CI], 0.05-0.70), a baseline Mathew score higher than 74 (OR, 11.5; 95% CI, 4.95-26.70), normal baseline CT findings (OR, 8.86; CI, 3.99-19.60), and early heparinization (OR, 1.7; 95% CI, 1.10-2.50). Targeted APTT ratios were achieved at 24 hours in fewer than 50% of patients. Whereas stroke recurrence was associated with lower mean APTT ratios, higher mean APTT ratios were observed in patients with symptomatic bleeding, especially on the day of bleeding. Age, admission stroke severity, blood pressure, and baseline CT findings did not predict hemorrhagic worsening.
Conclusions Delaying anticoagulation in alert patients with stroke and nonvalvular atrial fibrillation is not endorsed by the initial severity of symptoms or the early signs of infarction on CT scan. Functional recovery is improved the sooner heparin is administered. These findings suggest that heparin also has therapeutic properties. However, close APTT monitoring is warranted to lessen the incidence of untoward complications.
From the Neurology Service, Institut d'Investigacions Biomediques "August Pi i Sunyer" (IDIBAPS), University of Barcelona, (Drs Chamorro, Vila, and Blanc), and the Department of Epidemiology and Biostatistics, Hospital Clínic (Dr Ascaso), Barcelona, Spain.
RELATED ARTICLES
When Should Heparin Be Given to Patients With Atrial Fibrillation–Related Embolic Brain Infarcts?
Louis R. Caplan
Arch Neurol. 1999;56(9):1059-1060.
EXTRACT
| FULL TEXT
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(9):1169-1171.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Albers et al.
Chest 2008;133:630S-669S.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials
Paciaroni et al.
Stroke 2007;38:423-430.
ABSTRACT
| FULL TEXT
Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke
McCabe and Rakhit
J. Neurol. Neurosurg. Psychiatry 2007;78:14-24.
ABSTRACT
| FULL TEXT
Immediate Anticoagulation for Acute Stroke in Atrial Fibrillation: Yes
Chamorro
Stroke 2006;37:3052-3053.
FULL TEXT
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Albers et al.
Chest 2004;126:483S-512S.
ABSTRACT
| FULL TEXT
"Computed Tomography-Negative" Intracerebral Hemorrhage: Case Report and Implications for Management
Packard et al.
Arch Neurol 2003;60:1156-1159.
ABSTRACT
| FULL TEXT
Resolved: Heparin May Be Useful in Selected Patients With Brain Ischemia
Caplan
Stroke 2003;34:230-231.
FULL TEXT
Radiology of stroke
Jolobe and Wardlaw
J. Neurol. Neurosurg. Psychiatry 2002;73:96-96.
FULL TEXT
Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke
Moonis and Fisher
Stroke 2002;33:1927-1933.
ABSTRACT
| FULL TEXT
Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association
Hirsh et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21
:e9-e9.
FULL TEXT
Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association
Hirsh et al.
Circulation 2001;103:2994-3018.
FULL TEXT
Immediate Anticoagulation in Acute Focal Brain Ischemia Revisited : Gathering the Evidence
Chamorro
Stroke 2001;32:577-578.
FULL TEXT
Safety and Cost of Low-Molecular-Weight Heparin as Bridging Anticoagulant Therapy in Subacute Cerebral Ischemia
Kalafut et al.
Stroke 2000;31:2563-2568.
ABSTRACT
| FULL TEXT
Treatment of Acute Ischemic Stroke
Brott and Bogousslavsky
NEJM 2000;343:710-722.
FULL TEXT
What is the Role of Intravenous in Heparin Acute Stroke?
JWatch Neurology 2000;2000:4-4.
FULL TEXT
More on Heparin in Stroke
JWatch General 1999;1999:2-2.
FULL TEXT
When Should Heparin Be Given to Patients With Atrial Fibrillation-Related Embolic Brain Infarcts?
Caplan
Arch Neurol 1999;56:1059-1060.
FULL TEXT
|
